Effects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley rats

References

• GravalleseEMBone destruction in arthritisAnn Rheum Dis200261Suppl 2ii84612379632
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Chronic Conditions (UK)Rheumatoid Arthritis: National Clinical Guideline for Management and Treatment in AdultsLondon2009
   Google Scholar
• HuelinRPokoraTFosterTSMouldJFEconomic outcomes for celecoxib: a systematic review of pharmacoeconomic studiesExpert Rev Pharmacoecon Outcomes Res20121250552322971036
   PubMed Web of Science ®Google Scholar
• Guler-YukselMKlarenbeekNBGoekoop-RuitermanYPAccelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritisArthritis Res Ther201012R9620482894
   PubMed Web of Science ®Google Scholar
• KimSYSchneeweissSLiuJRisk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritisArthritis Res Ther201012R15420682035
   PubMed Web of Science ®Google Scholar
• VisMGuler-YukselMLemsWFCan bone loss in rheumatoid arthritis be prevented?Osteoporos Int2013242541255323775419
   PubMed Web of Science ®Google Scholar
• SchettGTeitelbaumSLOsteoclasts and arthritisJ Bone Miner Res20092411421146
   Web of Science ®Google Scholar
• NoguchiMKimotoASasamataMMiyataKMicro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis ratsJ Bone Miner Metab20082646146818758904
   PubMed Web of Science ®Google Scholar
• DurezPMalghemJNzeusseu ToukapATreatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisoloneArthritis Rheum2007563919392718050189
   PubMed Web of Science ®Google Scholar
• Da SilvaJAJacobsJWKirwanJRSafety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial dataAnn Rheum Dis20066528529316107513
   PubMed Web of Science ®Google Scholar
• TsuboiHNampeiAMatsuiYCelecoxib prevents juxta-articular osteopenia and growth plate destruction adjacent to inflamed joints in rats with collagen-induced arthritisMod Rheumatol20071711512217437166
   PubMedGoogle Scholar
• CranneyABMcKendryRJWellsGAThe effect of low dose methotrexate on bone densityJ Rheumatol2001282395239911708409
   PubMed Web of Science ®Google Scholar
• di MunnoOMazzantiniMSinigagliaLEffect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional studyJ Rheumatol2004311305130915229948
   PubMed Web of Science ®Google Scholar
• ZweersMCde BoerTNvan RoonJBijlsmaJWLafeberFPMastbergenSCCelecoxib: considerations regarding its potential disease-modifying properties in osteoarthritisArthritis Res Ther20111323921955617
   PubMed Web of Science ®Google Scholar
• OdioCMRamirezTAriasGDouble blind, randomized, placebo-controlled study of dexamethasone therapy for hematogenous septic arthritis in childrenPediatr Infect Dis J20032288388814551489
   PubMed Web of Science ®Google Scholar
• WangDMillerSCLiuXMAndersonBWangXSGoldringSRNovel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritisArthritis Res Ther20079R217233911
   PubMed Web of Science ®Google Scholar
• JurcovicovaJSvikKScsukovaSBauerovaKRovenskyJStancikovaMMethotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritisRheumatol Int2009291187119119156421
   PubMed Web of Science ®Google Scholar
• DempsterDWCompstonJEDreznerMKStandardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJ Bone Miner Res20132821723197339
   PubMed Web of Science ®Google Scholar
• CuiLLiTLiuYSalvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesisPloS one20127e3464722493705
   PubMed Web of Science ®Google Scholar
• LinSEHuangJPWuLZWuTCuiLPrevention of osteopenia and dyslipidemia in rats after ovariectomy with combined aspirin and low-dose diethylstilbestrolBiomed Environ Sci20132624925723534465
   PubMed Web of Science ®Google Scholar
• CuiLWuTLiQNLinLSLiangNCPreventive effects of ginsenosides on osteopenia of rats induced by ovariectomyActa pharmacol Sin20012242843411743891
   PubMed Web of Science ®Google Scholar
• LinSHuangJZhengLGlucocorticoid-induced osteoporosis in growing ratsCalcif Tissue Int20149536237325086673
   PubMed Web of Science ®Google Scholar
• BakkerMFJacobsJWWelsingPMLow-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trialAnn Intern Med201215632933922393128
   PubMed Web of Science ®Google Scholar
• KirwanJRBijlsmaJWBoersMSheaBJEffects of glucocorticoids on radiological progression in rheumatoid arthritisCochrane Database Syst Rev2007CD00635617253590
   PubMed Web of Science ®Google Scholar
• Van StaaTPLeufkensHGAbenhaimLZhangBCooperCUse of oral corticosteroids and risk of fractures. June, 2000J Bone Miner Res20052014871494 discussion 616149171
   PubMed Web of Science ®Google Scholar
• SaagKGKoehnkeRCaldwellJRLow dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse eventsAm J Med1994961151238109596
   PubMed Web of Science ®Google Scholar
• ShaneEBurrDEbelingPRAtypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral ResearchJ Bone Miner Res2010252267229420842676
   PubMed Web of Science ®Google Scholar
• TsujiSTomitaTNakaseTHamadaMKawaiHYoshikawaHCelecoxib, a selective cyclooxygenase-2 inhibitor, reduces level of a bone resorption marker in postmenopausal women with rheumatoid arthritisInt J Rheum Dis201417444924472266
   PubMed Web of Science ®Google Scholar
• KasukawaYMiyakoshiNSrivastavaAKThe selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivoTohoku J Exp Med200721127528317347553
   PubMed Web of Science ®Google Scholar
• KawashimaMFujikawaYItonagaITakitaCTsumuraHThe effect of selective cyclooxygenase-2 inhibitor on human osteoclast precursors to influence osteoclastogenesis in vitroMod Rheumatol20091919219819198759
   PubMed Web of Science ®Google Scholar
• IgarashiKWooJTSternPHEffects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitroBiochem Pharmacol20026352353211853703
   PubMed Web of Science ®Google Scholar
• YoonDSYooJHKimYHPaikSHanCDLeeJWThe effects of COX-2 inhibitor during osteogenic differentiation of bone marrow-derived human mesenchymal stem cellsStem Cells Dev2010191523153320095820
   PubMed Web of Science ®Google Scholar
• GoodmanSMaTTrindadeMCOX-2 selective NSAID decreases bone ingrowth in vivoJ Orthop Res2002201164116912472224
   PubMed Web of Science ®Google Scholar
• MurnaghanMLiGMarshDRNonsteroidal anti-inflammatory drug-induced fracture nonunion: an inhibition of angiogenesis?J Bone Joint Surg Am200688Suppl 314014717079380
   PubMed Web of Science ®Google Scholar
• MullerMRaabeOAddicksKWenischSArnholdSEffects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cellsCell Biol Int20113523524821087205
   PubMed Web of Science ®Google Scholar
• VisserKKatchamartWLozaEMultinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E InitiativeAnn Rheum Dis2009681086109319033291
   PubMed Web of Science ®Google Scholar
• CronsteinBNLow-dose methotrexate: a mainstay in the treatment of rheumatoid arthritisPharmacol Rev20055716317215914465
   PubMed Web of Science ®Google Scholar
• SinghJAFurstDEBharatA2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care Res201264625639
   PubMed Web of Science ®Google Scholar
• XianCJCoolJCSchererMACellular mechanisms for methotrexate chemotherapy-induced bone growth defectsBone20074184285017884747
   PubMed Web of Science ®Google Scholar
• FanCMFosterBKHuiSKXianCJPrevention of bone growth defects, increased bone resorption and marrow adiposity with folinic acid in rats receiving long-term methotrexatePloS one20127e4691523071661
   PubMed Web of Science ®Google Scholar
• XianCJCoolJCSchererMAFanCFosterBKFolinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cellsJ Cell Physiol200821477778517786974
   PubMed Web of Science ®Google Scholar
• FanCCoolJCSchererMADamaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatmentBone200944617018976724
   PubMed Web of Science ®Google Scholar
• MinaurNJKounaliDVediSCompstonJEBeresfordJNBhallaAKMethotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral densityRheumatology200241741749
   Web of Science ®Google Scholar